Advertisement

Oral Leukoplakia

  • Rajiv S. Desai
  • Ravikant S. Ganga
  • Raghav C. Dwivedi
Chapter
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

Oral leukoplakia (New Latin leuko, white, + classical Greek plax, flat object) is said to represent the most common premalignant oral mucosal lesion with an estimated global prevalence rate of 2.6%. Historically, practitioners have used many synonyms such as leucoma, smokers’ patch, leukokeratosis and ichthyosis for this lesion. In 1851, Sir James Paget documented a connection between a white keratotic oral lesion and lingual carcinoma; however, the term “leukoplakia” has given rise to considerable misunderstanding since it was first defined more than 140 years ago by the dermatologist Ernst Schwimmer in 1877 [1].

References

  1. 1.
    Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.CrossRefGoogle Scholar
  2. 2.
    Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6:147–60.CrossRefGoogle Scholar
  3. 3.
    Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45:155–66.CrossRefGoogle Scholar
  4. 4.
    Axell T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol. 1984;12:145–54.CrossRefGoogle Scholar
  5. 5.
    Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I. Histological typing of cancer and precancer of the oral mucosa. World Health Organization International histological classification of tumours. Berlin: Springer; 1997.CrossRefGoogle Scholar
  6. 6.
    Chi AC, Lambert PR, Pan Y, Li R, Vo DT, Edwards E, et al. Is alveolar ridge keratosis a true leukoplakia? A clinicopathologic comparison of 2,153 lesions. J Am Dent Assoc. 2007;138:641–51.CrossRefGoogle Scholar
  7. 7.
    Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): a distinct clinicopathologic entity. J Am Acad Dermatol. 2008;58:151–7.CrossRefGoogle Scholar
  8. 8.
    van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20:e685–92.CrossRefGoogle Scholar
  9. 9.
    van der Waal I. Greenspan lesion is a better term than “hairy leukoplakia”. J Oral Pathol Med. 1996;25:144.CrossRefGoogle Scholar
  10. 10.
    Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppasala, Sweden, May 18-21, 1994. International collaborative group on oral white lesions. J Oral Pathol Med. 1996;25:49–54.CrossRefGoogle Scholar
  11. 11.
    Mehta FS, Hammer JE. Tobacco-related oral mucosal lesions and conditions in India, A guide for dental students, dentists, and physicians. Bombay: Basic Dental Research Unit, Tata Institute of Fundamental Research; 1993.Google Scholar
  12. 12.
    Warnakulasuriya S, Dietrich T, Bornstein MM, Casals PE, Preshaw PM, Walter C, et al. Oral health risks of tobacco use and effects of cessation. Int Dent J. 2010;60:7–30.PubMedGoogle Scholar
  13. 13.
    Gupta PC, Mehta FS, Daftary DK. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dental and Oral Epidemiology. 1980;8:287–333.CrossRefGoogle Scholar
  14. 14.
    van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317–23.CrossRefGoogle Scholar
  15. 15.
    Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1–10.CrossRefGoogle Scholar
  16. 16.
    Khan Z, Khan S, Christianson L, Rehman S, Ekwunife O, Samkange-Zeeb F. Smokeless tobacco and oral potentially malignant disorders in South Asia: a systematic review and meta-analysis. Nicotine Tob Res. 2016;5:142.Google Scholar
  17. 17.
    van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46:423–5.CrossRefGoogle Scholar
  18. 18.
    Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin. 2000;50:7–33.CrossRefGoogle Scholar
  19. 19.
    Paricio-Rubio J, Revenga-Arranz J, Ramírez-Gasca T, Boned-Blas P. Leucoqueratosis nicotínica del paladar. Actas Dermosifiliogr. 2002;93:38–41.CrossRefGoogle Scholar
  20. 20.
    Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Ondontol Scand. 1965;23:239–56.CrossRefGoogle Scholar
  21. 21.
    Renstrup G. Occurrence of candida in oral leukoplakias. Acta Pathol Microbiol Scand. 1970;78:421–4.Google Scholar
  22. 22.
    Palefsky JM, Silverman S, Abdel‐Salaam M, Daniels TE, Greenspan JS. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med. 1995;24:193–7.CrossRefGoogle Scholar
  23. 23.
    Praetorius F. HPV-associated diseases of oral mucosa. Clin Dermatol. 1997;15:299–413.CrossRefGoogle Scholar
  24. 24.
    Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a metaanalysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622–35.CrossRefGoogle Scholar
  25. 25.
    Bagán JV, Jiménez Y, Murillo J, Poveda R, Díaz JM, Gavaldá C, et al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: a preliminary study. Med Oral Patol Oral Cir Bucal. 2008;13:E110–3.PubMedGoogle Scholar
  26. 26.
    Salati NA, Khwaja KJ, Anwer M. Pathogenesis of potentially malignant disorders. Guident. 2012;5:60–2.Google Scholar
  27. 27.
    van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997;33:291–301.CrossRefGoogle Scholar
  28. 28.
    Warnakulasuriya S, Johnson NW, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.CrossRefGoogle Scholar
  29. 29.
    Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60:285–98.CrossRefGoogle Scholar
  30. 30.
    Bagan JV, Jiménez-Soriano Y, Diaz-Fernandez JM, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Oral Oncol. 2011;47:732–5.CrossRefGoogle Scholar
  31. 31.
    Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA, Esparza-Gómez G, Bagán JV. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2010;15:e839–45.CrossRefGoogle Scholar
  32. 32.
    Carrard VC, Brouns EREA, van der Waal I. Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2013;18:e411–3.CrossRefGoogle Scholar
  33. 33.
    Cabay RJ, Morton TH, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med. 2007;36:255–61.CrossRefGoogle Scholar
  34. 34.
    Pindborg JJ, Reibel J, Roed-Petersen B, Mehta FS. Tobacco-induced changes in oral leukoplakic epithelium. Cancer. 1980;45:2330–6.CrossRefGoogle Scholar
  35. 35.
    Daniels TE, Hansen LS, Greenspan JS, et al. Histopathology of smokeless tobacco lesions in professional baseball players. Association with different types of tobacco. Oral Surg Oral Med Oral Pathol. 1992;73:720–5.CrossRefGoogle Scholar
  36. 36.
    Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:321–9.CrossRefGoogle Scholar
  37. 37.
    Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Endod. 1995;80:188–91.CrossRefGoogle Scholar
  38. 38.
    Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1972;33:389–99.CrossRefGoogle Scholar
  39. 39.
    Bánóczy J. Follow up studies in oral leukoplakia. J Maxillofac Surg. 1977;5:69–75.CrossRefGoogle Scholar
  40. 40.
    Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7:18–24.PubMedGoogle Scholar
  41. 41.
    Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42:987–93.CrossRefGoogle Scholar
  42. 42.
    Parlatescu I, Gheorghe C, Coculescu E, Tovaru S. Oral leukoplakia–an update. Maedica. 2014;9:88.PubMedPubMedCentralGoogle Scholar
  43. 43.
    van der Waal I, Schepman KP, Van der Meij EH. A modified classification and staging system for oral leukoplakia. Oral Oncol. 2000;36:264–6.CrossRefGoogle Scholar
  44. 44.
    Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47–62.CrossRefGoogle Scholar
  45. 45.
    Kramer IR, el-Labban N, Lee KW. The clinical features and risk of malignant transformation in sublingual keratosis. Nr Dent J. 1978;144:171–80.CrossRefGoogle Scholar
  46. 46.
    Duncan KO, Geisse JK, Leffel DJ. Epidermal and appendageal tumors. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York, NY: McGraw Hill; 2007. p. 1024–6.Google Scholar
  47. 47.
    Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent. 2012;2012:1–7.CrossRefGoogle Scholar
  48. 48.
    Nasser W, Flechtenmacher C, Holzinger D, et al. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol Med. 2011;40:629–35.CrossRefGoogle Scholar
  49. 49.
    Reddy SG, Reddy SG, Kanala S, et al. The sensitivity and specificity of computerized brush biopsy and scalpel biopsy in diagnosing oral premalignant lesions: a comparative study. J Oral Maxillofac Pathol. 2012;16:349–53.CrossRefGoogle Scholar
  50. 50.
    Lingen MW, Kalmar JR, Karrison T, et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22.CrossRefGoogle Scholar
  51. 51.
    Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011;40:541–4.CrossRefGoogle Scholar
  52. 52.
    Ganga RS, Gundre D, Bansal S, Shirsat PM, Prasad P, Desai RS. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope. Oral oncology. 2017;75:67–74.CrossRefGoogle Scholar
  53. 53.
    Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;(4):CD001829.Google Scholar
  54. 54.
    Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl S19):e1–12.Google Scholar
  55. 55.
    Ho MW, Risk JM, Woolgar JA, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48:969–76.CrossRefGoogle Scholar
  56. 56.
    William WN. Oral premalignant lesions. Curr Opin Oncol. 2012;24:205–10.CrossRefGoogle Scholar
  57. 57.
    Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008;37:63–9.CrossRefGoogle Scholar

Copyright information

© Peter A. Brennan, Tom Aldridge, Raghav C. Dwivedi, Rehan Kazi 2019

Authors and Affiliations

  • Rajiv S. Desai
    • 1
  • Ravikant S. Ganga
    • 1
  • Raghav C. Dwivedi
    • 2
  1. 1.Department of Oral Pathology and MicrobiologyNair Hospital Dental CollegeMumbaiIndia
  2. 2.Department of Otolaryngology Head Neck SurgeryQueen Alexandra HospitalPortsmouthUK

Personalised recommendations